Lv1
60 积分 2024-08-27 加入
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2− Breast Cancer: Impact of Tumor Ki67 and ER Status
1天前
待确认
Prognostic Impact of HER2-Low and HER2-Zero in Resectable Breast Cancer with Different Hormone Receptor Status: A Landmark Analysis of Real-World Data from the National Cancer Center of China
4个月前
已完结
A review of prognostic and predictive biomarkers in breast cancer
5个月前
已完结
皖公网安备34019202002308
